Deliver remaining ACAM2000 units under the July 2021 option exercise
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 4 Nov 2021
- Due
- 31 Dec 2021
- Checked
- 1 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Company expects to deliver the remaining units under this option exercise during the fourth quarter of 2021.”
What we found
Evidence strength A What the grades mean
The company stated in 2023 that it completed the delivery of all ACAM2000 doses from the July 2021 option exercise in 2022, missing the original Q4 2021 deadline.
-
A Emergent BioSolutions Inc. 10-K filed 2023-03-01
“On July 13, 2021, we announced the exercise by HHS of the second contract option, valued at $182.2 million, to procure doses of ACAM2000 vaccine. We completed the delivery of all ACAM2000 doses in 2022.” ✓ confirmed on the page
Market reaction: the shares moved -7.8% against the S&P 500 over the three sessions around the disclosure (28 Feb 2023 to 3 Mar 2023). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Delivery
- Indicative materiality
- Medium rules
- Action
- Deliver
- Deliverable
- ACAM2000 units
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Customer
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Emergent BioSolutions Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-EBS-002470 · Corrections policy